Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
10
Number of overlapping holdings
11.2%
% of SBIO's 89 holdings also in IBRN
24.4%
% of IBRN's 55 holdings also in SBIO
Overlap by Weight
Sector Drift (SBIO minus IBRN)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in SBIO |
Weight in IBRN |
Overlap | |
|---|---|---|---|---|
 |
ALKERMES PLC | 3.6% | 4.6% | 3.6% |
 |
PTC THERAPEUTICS INC | 2.5% | 6.0% | 2.5% |
|
ACADIA PHARMACEUTICALS INC | 2.1% | 4.4% | 2.1% |
|
EDGEWISE THERAPEUTICS, INC. | 1.8% | 3.2% | 1.8% |
|
ANAVEX LIFE SCIENCES CORP. | 0.5% | 1.4% | 0.5% |
Position Highlights (Non-Overlapping Exposures)
SBIO Overweight Relative to IBRN
|
CORCEPT THERAPEUTICS INC | 4.2% |
|
KRYSTAL BIOTECH, INC. | 3.4% |
|
ARCELLX, INC. | 3.2% |
|
CRINETICS PHARMACEUTICALS INC | 3.1% |
|
AVIDITY BIOSCIENCES INC | 2.7% |
|
DENALI THERAPEUTICS INC. | 2.3% |
 |
MERUS N.V. | 2.2% |
 |
MOONLAKE IMMUNOTHERAPEUTICS CLASS A | 2.1% |
|
VERICEL CORPORATION | 2.0% |
|
AMICUS THERAPEUTICS INC | 2.0% |
SBIO Underweight Relative to IBRN
|
SCHOLAR ROCK HOLDING CORP. | -5.5% |
|
INTRA-CELLULAR THERAPIES INC | -4.6% |
 |
ARGENX SE ADR | -4.5% |
|
CATALYST PHARMACEUTICAL PART | -4.4% |
|
NEUROCRINE BIOSCIENCES INC | -4.3% |
|
SAREPTA THERAPEUTICS INC | -3.9% |
 |
SK BIOPHARMACEUTICALS CO., LTD. | -3.8% |
|
SUPERNUS PHARMACEUTICALS INC | -3.8% |
|
PTC THERAPEUTICS INC | -3.4% |
|
DYNE THERAPEUTICS INC | -3.2% |